FDA Approves OsteoFab Orthopedic DeviceOxford Performance Materials has received FDA 510(k) clearance for its OsteoFab Patient Specific Cranial Device.
The OsteoFab is OPM's brand name for device parts additively manufactured from PEKK polymer, according to the report. Implants created using the 3-D printing process can be specifically shaped to each patient's anatomy. OsteoFab is one of the first additively manufactured polymer implants to receive FDA approval.
Patient specific implants, such as the OsteoFab, can assist in replacing skull voids due to trauma or disease.
More Articles on Supply Chain:
Dr. Richard Kube Performs First Coflex Interlaminar Implant in Illinois
Sports Medicine Device Sales Increase Arthrocare's 4Q Revenue by 4.9%
Dr. D. Kevin Lester Performs First US Knee Replacements With NavioPFS
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest ASC news and feature stories from Becker's ASC Review, sign-up for the free Becker's ASC Review E-weekly by clicking here.
- Senate Introduces Companion Medicare RAC Reform Bill
- Drs. Brian Cole, Anthony Romeo of Midwest Orthopaedics at Rush Among Top Orthopedic Surgeons Contributing to Orthopedic Literature
- Spinal Elements Upgrades to 40,000-Square-Foot Headquarters
- UnitedHealth, Aetna, Cigna to Sit Out of California's Health Insurance Exchange
- Rhode Island Nixes "Confidential" Prices Between Payors, Providers